Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Association of GRIA1 polymorphisms with ovarian response to human menopausal gonadotropin in Iranian women

  • Received : 2019.10.02
  • Accepted : 2020.02.10
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: Glutamate ionotropic receptor AMPA type subunit 1 (GRIA1) is a subunit of a ligand-gated ion channel that regulates the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) by controlling the release of gonadotropin-releasing hormone. Few studies have investigated the association between the GRIA1 gene and human infertility. This study evaluated the association of the GRIA1 rs548294 C > T and rs2195450 G > A polymorphisms with the ovarian response to human menopausal gonadotropin (HMG) in Iranian women. Methods: One hundred women with histories of at least 1 year of infertility were included. On the second day of menstruation, patients were injected with HMG; on the third day, blood samples were collected. After hormonal analysis, the GRIA1 rs548294 C > T and rs2195450 G > A genotypes of samples were identified via the restriction fragment length polymorphism method, and on day 9, the number of follicles was assessed via ultrasound. Results: For the GRIA1 rs548294 C > T and rs2195450 G > A single nucleotide polymorphisms, the subjects with CT and GG genotypes, respectively, displayed the highest mean FSH level, LH level, and number of follicles on day 9 of the menstrual cycle (p< 0.05). Significant positive correlations were observed between LH and FSH (p< 0.01), LH and follicle count (p< 0.01), FSH and age (p< 0.05), follicle count and age (p= 0.048), and FSH and follicle count (p< 0.01). Conclusion: This study showed a significant relationship between GRIA1 polymorphisms and ovarian response to the induction of ovulation. Therefore, determining patients' GRIA1 genotype may be useful for improving treatment and prescribing suitable doses of ovulation-stimulating drugs.

Keywords

References

  1. Lee HS, Park YS, Lee JS, Seo JT. Serum and seminal plasma insulin-like growth factor-1 in male infertility. Clin Exp Reprod Med 2016;43:97-101. https://doi.org/10.5653/cerm.2016.43.2.97
  2. Faduola P, Kolade CO. Sperm chromatin structure assay results in Nigerian men with unexplained infertility. Clin Exp Reprod Med 2015;42:101-5. https://doi.org/10.5653/cerm.2015.42.3.101
  3. Han HD, Lim CK, Youm HS, Hyon NN, Lee JH, Hong M. The effect of low concentrated hypoxanthine and FSH in 10% FBS supplemented medium on immature oocyte in vitro maturatio. Korean J Reprod Med 2009;36:175-86.
  4. Kavousi M, Khadem Ghaebi N, Tansaz M, Bioos S, Feyzabadi Z. Comparison of the causes of infertility induced by ovulation disorders in Persian medicine and traditional medicine. Iran J Obstet Gynecol Infertil 2018;21:80-91.
  5. Richards JS, Ascoli M. Endocrine, Paracrine, and autocrine signaling pathways that regulate ovulation. Trends Endocrinol Metab 2018;29:313-25. https://doi.org/10.1016/j.tem.2018.02.012
  6. Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext. South Dartmouth: MDText.com; 2018.
  7. Lee JI, Hur YM, Jeon ES, Yoon JI, Jung GS, Hong KE, et al. Comparison of pregnancy rates by intrauterine insemination after ovulation trigger with endogenous LH surge, GnRH agonist or hCG in stimulated cycles. Korean J Fertil Steril 1999;26:389-98.
  8. Bai SW, Kim JY, Won JG, Jung CJ, Chang KH, Lee BS, et al. Subcutaneous administration of highly purified-FSH(HP-FSH) versus intramuscular administration of FSH in superovulation for IVFET. Korean J Fertil Steril 1997;24:135-41.
  9. Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities. Clin Exp Reprod Med 2014;41:41-6. https://doi.org/10.5653/cerm.2014.41.2.41
  10. Woo JH, Choi KH, Kim BS, An GH, Kim YY, Chae YH. Heterotopic pregnancy in polycystic ovary syndrome woman conceived after ovulation induction by clomiphene citrate: a case of bilateral tubal pregnancies and intrauterine twin pregnancy. Korean J Reprod Med 2010;37:261-6.
  11. Lee EJ, Park HJ, Yang HI, Lee KE, Seo SK, Kim HY, et al. Clinical efficacy of clomiphene citrate and letrozole combined with gonadotropins for superovulation in patients with clomiphene-induced thin endometrium. Korean J Reprod Med 2009;36:111-9.
  12. Yoon JS, Choi YM, Lim KS, Hur CY, Kang YJ, Jung JH, et al. The effect of follicle-stimulating hormone receptor (FSHR) polymorphism on outcomes of controlled ovarian hyperstimulation (COH) and in-vitro fertilization and embryo transfer (IVF-ET). Korean J Fertil Steril 2004;31:133-9.
  13. Chappell N, Gibbons WE. The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome. Clin Exp Reprod Med 2017;44:57-62. https://doi.org/10.5653/cerm.2017.44.2.57
  14. Lee JE, Lee JR, Jee BC, Suh CS, Kim KC, Lee WD, et al. Clinical application of anti-Mullerian hormone as a predictor of controlled ovarian hyperstimulation outcome. Clin Exp Reprod Med 2012;39:176-81. https://doi.org/10.5653/cerm.2012.39.4.176
  15. Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, et al. 68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience. J Nucl Med 2017;58:81-4. https://doi.org/10.2967/jnumed.116.181800
  16. Rahmani E, Ahmadi S, Motamed N, Yazdani N. Study of association between ovarian volume with the number of antral follicles and third day of menstruation FSH in infertile patients referred to Omid Persian gulf infertility Clinic. Iran South Med J 2016;19:608-19. https://doi.org/10.18869/acadpub.ismj.19.4.608
  17. Nam YS, Cho YS, Lee WS, Kim NK, Kim SH, Cha KY. A study of luteinizing hormone in patients with infertility and recurrent spontaneous abortion. Korean J Fertil Steril 2002;29:91-6.
  18. Kim DS, Shin SJ, Kim HY, Lee HY, Park JY, Park YS. Induction of ovulation by intermittent subcutaneous injection of pure follicle-stimulating hormone in polycystic ovarian syndrome. Korean J Fertil Steril 1993;20:125-30.
  19. Gao X, Wang J. Quantitative assessment of the association between GRIA1 polymorphisms and migraine risk. Biosci Rep 2018;38:BSR20181347. https://doi.org/10.1042/BSR20181347
  20. Chen SH, Pei D, Yang W, Cheng C, Jeha S, Cox NJ, et al. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther 2010;88:191-6. https://doi.org/10.1038/clpt.2010.94
  21. Formicola D, Aloia A, Sampaolo S, Farina O, Diodato D, Griffiths LR, et al. Common variants in the regulative regions of GRIA1 and GRIA3 receptor genes are associated with migraine susceptibility. BMC Med Genet 2010;11:103. https://doi.org/10.1186/1471-2350-11-103
  22. Fang J, An X, Chen S, Yu Z, Ma Q, Qu H. Case-control study of GRIA1 and GRIA3 gene variants in migraine. J Headache Pain 2015;17:2. https://doi.org/10.1186/s10194-016-0592-2
  23. Sugimoto M, Sasaki S, Watanabe T, Nishimura S, Ideta A, Yamazaki M, et al. Ionotropic glutamate receptor AMPA 1 is associated with ovulation rate. PLoS One 2010;5:e13817. https://doi.org/10.1371/journal.pone.0013817
  24. Cushman RA, Miles JR, Rempel LA, McDaneld TG, Kuehn LA, Chitko-McKown CG, et al. Identification of an ionotropic glutamate receptor AMPA1/GRIA1 polymorphism in crossbred beef cows differing in fertility. J Anim Sci 2013;91:2640-6. https://doi.org/10.2527/jas.2012-5950
  25. Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, et al. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod 2015;30:2376-86. https://doi.org/10.1093/humrep/dev195
  26. Deb S, Campbell BK, Clewes JS, Pincott-Allen C, Raine-Fenning NJ. Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles. Ultrasound Obstet Gynecol 2013;41:216-22. https://doi.org/10.1002/uog.11226
  27. Shi L, Zhang J, Lai Z, Tian Y, Fang L, Wu M, et al. Long-term moderate oxidative stress decreased ovarian reproductive function by reducing follicle quality and progesterone production. PLoS One 2016;11:e0162194. https://doi.org/10.1371/journal.pone.0162194
  28. Morel MC, Newcombe JR, Hayward K. Factors affecting pre-ovulatory follicle diameter in the mare: the effect of mare age, season and presence of other ovulatory follicles (multiple ovulation). Theriogenology 2010;74:1241-7. https://doi.org/10.1016/j.theriogenology.2010.05.027
  29. Patrelli TS, Gizzo S, Sianesi N, Levati L, Pezzuto A, Ferrari B, et al. Anti-Mullerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles? PLoS One 2012;7:e44571. https://doi.org/10.1371/journal.pone.0044571
  30. Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9:116. https://doi.org/10.1186/1477-7827-9-116
  31. Moeini A, Shafieizadeh N, Vahid Dastjerdi M, Majidi SH, Eslami B. The effect of age on ovarian reserve markers in tehranian women with fertility. Int J Endocrinol Metab 2008;6:114-9.
  32. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, teJong FH, et al. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 2003;18:700-6. https://doi.org/10.1093/humrep/deg135

Cited by

  1. Transcriptome sequencing identified the ceRNA network associated with recurrent spontaneous abortion vol.14, pp.1, 2020, https://doi.org/10.1186/s12920-021-01125-4